An Eli Lilly spokesperson noted that the federal court presiding over these claims ruled last summer that any plaintiff claiming to have had drug-induced gastroparesis must have had a gastric emptying study properly performed at the time of diagnosis, confirming the diagnosis, and it recognized that its ruling meant some plaintiffs will be unable to prove that they suffered from gastroparesis. Lilly appreciates the Courts careful consideration of this and other threshold issues, and we will continue to defend against these claims in court. The first "bellwether test trials are not expected until 2027, plaintiffs attorneys said
In case of accidental overdose, seek professional assistance or contact a poison control centre immediately
California buyers should verify the product label and any applicable Proposition 65 warnings published by the manufacturer before purchase
The neuroprotective potential of carotenoids in vitro and in vivo
Additionally, these modifications may induce significant toxicity by triggering immune responses 46,47
Eyes (NAION): EMA concluded in June 2025 that NAION is a very rare side effect of semaglutide (1 in 10,000)
/assets/images/provider/photos/2798511.png)
